IRIS

Sfoglia per Autore  

Opzioni
Mostrati risultati da 1 a 50 di 142
Titolo Data di pubblicazione Autore(i) File
Side effects of imipramine therapy in enuretic children. 1-gen-1990 Montanari, G; Baraldo, Massimo; Zara, G; Benetello, P; Secchieri, S; Furlanut, Mario
Imipramine pharmacokinetics in depressed geriatric patients 1-gen-1990 Benetello, P; Furlanut, Mario; Zara, G; Baraldo, Massimo
FARMACOLOGIA CLINICA DELL'ENURESI PRIMARIA 1-gen-1990 Montanari, G.; Baraldo, Massimo; Zara, G.; Furlanut, Mario
Chlorpromazine disposition in relation to age in children 1-gen-1990 Furlanut, Mario; Benetello, P; Baraldo, Massimo; Zara, G; Montanari, G; Donzelli, F.
Plasma levels of levodopa. Its main metabolites and carbidopa after conventional and slow release levodopa-carbidopa treatment in parkinsonian patients. 1-gen-1990 Baraldo, Massimo; Zara, G; Benetello, P; Furlanut, Mario
CYCLOSPORINE-A (CSA) PLUS CHEMOTHERAPY (CHT) IN-VIVO, TO OVERCOME MULTIDRUG-RESISTANCE (MDR) 1-gen-1993 Fanin, Renato; Damiani, Daniela; Michieli, M; Cerno, M; Michelutti, A; Baraldo, Massimo; Furlanut, Mario; Baccarani, Michele; Tura, S
Plasma levels of levodopa and its main metabolites in parkinsonian patients after conventional and controlled-release levodopa-carbidopa associations. 1-gen-1993 Benetello, P; Furlanut, M; Zara, G; Baraldo, Massimo; Hassan, E.
CYCLOSPORINE-A PLUS CHEMOTHERAPY IN ACUTE MYELOID-LEUKEMIA 1-gen-1994 Fanin, Renato; Damiani, Daniela; Michieli, M; Cerno, M; Candoni, A; Michelutti, A; Baraldo, M; Russo, D; Furlanut, M.; Baccarani, M.
Somatomedin C (insulin-like growth factor 1) levels decrease during acute changes of stress related hormones. Relevance for fibromyalgia. 1-gen-1994 Ferraccioli, Gianfranco; Guerra2, P2; Rizz3, V3; Baraldo, Massimo; Salaffi5, F5; Furlanut, Mario
No effect of clodronate on cyclosporin A blood levels in heart transplant patients simultaneously treated with diltiazem and azathioprine. 1-gen-1994 Baraldo, Massimo; Furlanut, Mario; Puricelli, C.
Effect of fluctuations of blood cyclosporine concentrations on renal function. 1-gen-1994 Furlanut, Mario; Baraldo, Massimo; Pea, Federico; Albanese4, Mariacristina4; Albertini5, Aldo5; Puricelli6, C. 6.
Oral and intravenous disposition of cyclosporine in psoriatic patients. 1-gen-1995 Galla, F; Marzocchi, V; Croattino, L; Poz, Donatella; Baraldo, Massimo; Furlanut, Mario
Enhancement of idarubicin content in leukemic cells with cyclosporin in vivo: a report of two cases 1-gen-1995 Damiani, Daniela; Michieli, M.; Pea, F.; Baraldo, Massimo; Fanin, R.; Russo, D.; Furlanut, M.; Baccarani, M.
Calculating percentage prediction error: a user's note 1-gen-1995 Wu, Guang; Baraldo, Massimo; Furlanut, Mario
P170-related multidrug resistance. Enhancement of idarubicin content in leukemic cells with cyclosporin in vivo: a report of two cases 1-gen-1995 Damiani, Daniela; Michieli2, M2; Michelutti3, A3; Pea, Federico; Baraldo, Massimo; Fanin, Renato; Russo7, D7; Furlanut, Mario; Baccarani9, Michele9
Effects of different sampling strategies on predictions of blood cyclosporine concentrations in haematological patients with multidrug resistance by Bayesian and non-linear least squares methods 1-gen-1995 Wu, Guang; Baraldo, Massimo; Pea, Federico; Cossettini4, P4; Furlanut, Mario
Cyclosporin nephrotoxicity in relation to its metabolism in psoriasis 1-gen-1996 Furlanut, Mario; Baraldo, Massimo; Galla3, F3; Marzocchi4, V4; Pea, Federico
Blood concentrations and clinical effect of cyclosporin in psoriasis 1-gen-1996 Furlanut, Mario; Baraldo, Massimo; Pea, Federico; Marzocchi, V.; Croattino, L.; Galla, F.
Cyclosporin nephrotoxicity in relation to its pharmacokinetics in man 1-gen-1997 Furlanut, Mario; Baraldo, Massimo; Pea, Federico
Preliminary observations on serum concentrations of tamoxifen and its main metabolites in patients with breast cancer 1-gen-1997 Franceschi, Loretta; Baraldo, Massimo; Pea, Federico; Cartei4, G. 4.; Furlanut, Mario
Multidrug resistance modulation in vivo. The effect of cyclosporin alone or with dextro-verapamil on idarubicin pharmacokinetics in acute leukemia 1-gen-1997 Damiani, Daniela; Pea, Federico; Michieli, Mariagrazia; Ermacora4, A4; Baraldo, Massimo; Russo6, D6; Fanin, Renato; Furlanut, Mario; Baccarani, Michele
Oral gabapentin disposition in patients with epilepsy after a high-protein meal 1-gen-1997 Benetello, Pierpaola; Furlanut, Mario; Fortunato3, M3; Baraldo, Massimo; Pea, Federico; Tognon6, A6; Testa7, G. 7.
Levodopa and 3-O-methyldopa in cerebrospinal fluid after levodopa-carbidopa association 1-gen-1997 Benetello, P.; Furlanut, Mario; Fortunato, M.; Pea, Federico; Baraldo, Massimo
Monitoraggio del Gabapentine e della Lamotrigina in pazienti con crisi parziali complesse 1-gen-1997 Benetello, P.; Fortunato, M.; Tognon, A.; Testa, G. F.; Baraldo, Massimo; Pea, Federico; Furlanut, Mario
Farmacocinetica di due formulazioni di ciclosporina A in pazienti dermatologici 1-gen-1998 Frattasio, A; Baraldo, Massimo; Stinco, Giuseppe; Pea, F; De Francesco, V; Furlanut, M; Patrone, Pasquale
Adjuvant treatment with cyclosporin A increases the toxicity of chemotherapy for remission induction in acute non-lymphocytic leukemia. 1-gen-1998 Damiani, Daniela; Michieli2, M2; Ermacora3, A3; Russo4, D4; Fanin, Renato; Zaja, Francesco; Baraldo, Massimo; Pea, Federico; Furlanut, Mario; Baccarani, Michele
Inter-patient and intra-patient variations in the baseline tapping test in patients with Parkinson's disease 1-gen-1999 Wu, G.; Baraldo, Massimo; Furlanut, Mario
Isoniazid and its hydrazine metabolite in patients with tuberculosis 1-gen-1999 Pea, Federico; Milaneschi, R.; Baraldo, Massimo; Talmassons, G.; Furlanut, Mario
Pharmacokinetic profile of two different administration schemes of teicoplanin. Single 400 mg intravenous dose vs double-refracted 200 mg intramuscular doses in healthy volunteers 1-gen-1999 Pea, Federico; Furlanut, Mario; Poz, Donatella; Baraldo, Massimo
Multidrug resistance modulation in vivo: the effect of cyclosporin A alone or with dexverapamil on idarubicin pharmacokinetics in acute leukemia. 1-gen-1999 Pea, Federico; Damiani, Daniela; Michieli3, M3; Ermacora4, A4; Baraldo, Massimo; Russo6, D6; Fanin, Renato; Baccarani, Michele; Furlanut9, Mario9
Cyclosporine A pharmacokinetics in rheumatoid arthritis patients after 6 months of methotrexate therapy 1-gen-1999 Baraldo, Massimo; Ferraccioli, Gianfranco; Pea, Federico; Gremese4, E4; Furlanut, Mario
High vancomycin dosage regimens required by intensive care unit patients cotreated with drugs to improve haemodynamics following cardiac surgical procedures 1-gen-2000 Pea, Federico; Porreca2, L2; Baraldo, Massimo; Furlanut, Mario
Liposomal daunorubicin plasmatic and renal disposition in patients with acute leukemia 1-gen-2000 Pea, Federico; Russo2, D2; Michieli3, M3; Baraldo, Massimo; Ermacora5, A5; Damiani, Daniela; Baccarani, Michele; Furlanut, Mario
Ciprofloxacin disposition in elderly patients with LRTI being treated with sequential therapy (200 mg intravenously twice daily followed by 500 mg per os twice daily): Comparative pharmacokinetics and the role of therapeutic drug monitoring 1-gen-2000 Pea, Federico; Baraldo, Massimo; Lugatti, Emilio; Talmassons, Giovanni; Furlanut, Mario; Milaneschi, R
Optimisation of vancomycin regimen in neutropenic haematological patients with normal renal function. Multiple daily doses may be preferable 1-gen-2000 Pea, Federico; Poz, Donatella; Baraldo, Massimo; Furlanut, Mario
Cerebrospinal fluid penetration of levofloxacin in patients with spontaneous acute bacterial meningitis 1-gen-2001 Scotton, Pg; Pea, Federico; Giobbia, M; Baraldo, Massimo; Vaglia, A; Furlanut, Mario
Pharmacokinetics of two oral cyclosporin a formulations in clinically stable heart-transplant patients 1-gen-2001 Baraldo, Massimo; Pea, Federico; Poz3, Donatella3; Furlanut, Mario
Cyclosporine dose fractioning might affect renal function in stable heart transplanted patients 1-gen-2001 Baraldo, Massimo; Pea, Federico; Poz, D.; Albanese, M. C.; Livi, Ugolino; Furlanut, Mario
C(2) monitoring of cyclosporine in stable heart transplant patients after two daily and three daily doses. 1-gen-2002 Baraldo, Massimo; Francesconi2, Anna2; Barbone, Fabio; Tursi4, Vincenzo4; Livi, Ugolino; Furlanut, Mario
Therapeutic drug monitoring of lamotrigine in patients suffering from resistant partial seizures 1-gen-2002 Benetello, P.; Furlanut, Mario; Baraldo, Massimo; Tonon, A.; Furlanut, M.
GVHD and cyclosporien levels in blood in different moments after allogeneic bone marrow transplantation: an open question? 1-gen-2003 Skert, C.; Damiani, Daniela; Baraldo, Massimo; Socchir, ; Tiribelli, Mario; Sperotto, A.; Brollo, L.; Fanin, R.
AM and PM C2 monitoring of cyclosporine in liver transplant recipients 1-gen-2003 Baraldo, Massimo; Pavan, F; Brollo, L; Di Qual, E; Franceschi, L; Furlanut, Mario
Circadian variations in cyclosporine C2 concentrations during the first 2 weeks after liver transplantation. 1-gen-2003 Baraldo, Massimo; Risaliti, Andrea; Bresadola, Fabrizio; Chiarandini, Paolo; DELLA ROCCA, Giorgio; Furlanut, Mario
Limited sampling strategy for the determination of mycophenolic acid area under the curve in adult heart transplanted patients. 1-gen-2005 Baraldo, Massimo; Francesconi, A.; Isola, Miriam; Feruglio, M. T.; Franceschi, L.; Tursi, V.; Livi, Ugolino; Furlanut, M.
Tossicologia Clinica 1-gen-2005 Baraldo, Massimo
MEZZI DI CONTRASTO 1-gen-2005 Baraldo, Massimo
Therapeutic mycophenolic acid monitoring by means of limited sampling strategy in orthotopic heart transplant patients 1-gen-2005 Baraldo, Massimo; Isola, Miriam; Feruglio, Mt; Francesconi, A.; Franceschi, Loretta; Tursi, V.; Livi, Ugolino; Furlanut, Mario
Pharmacokinetic of protease inhibitors based regimens in 3 liver transplantation HCV/HIV coinfected patients. 1-gen-2005 By:adani, Gl; Baccarani, Umberto; Tavio, Marcello; Sainz, Mauricio; Lorenzin, Dario; Pea, Federico; Baraldo, Massimo; Bresadola, Vittorio; Risallti, A; Viale, Pierluigi; Bresadola, Fabrizio
Relevance of Mycophenolate Mofetil Therapeutic Drug Monitorino in hearth transplantation 1-gen-2006 M., Molinaro; C., Carazzone; D., Barbaro; C., Pellegrini; M., Viganò; M, Cotrufo; Livi, Ugolino; Baraldo, Massimo; M., Furlanut
Relevants of Mycophenolate mofetil therapeutic drug monitoring in heart transplantation 1-gen-2006 Molinaro, M; Carazzone, C; Barbano, D; Pellegrini, C; Viganò, M; Cotrufo, M; Livi, Ugolino; Baraldo, Massimo; Furlanut, M; Vitali, E; Zoppi, F; Regazzi, M.
Mostrati risultati da 1 a 50 di 142
Legenda icone

  •  file ad accesso aperto
  •  file disponibili sulla rete interna
  •  file disponibili agli utenti autorizzati
  •  file disponibili solo agli amministratori
  •  file sotto embargo
  •  nessun file disponibile